Cost-effectiveness analysis of insecticide ban aimed at preventing Parkinson's disease in Central California

Sci Total Environ. 2024 Feb 20:912:168913. doi: 10.1016/j.scitotenv.2023.168913. Epub 2023 Nov 30.

Abstract

Background: Our study assessed whether banning specific insecticides to reduce the PD burden in three Central California (CA) counties is cost-effective.

Method: We applied a cost-effectiveness analysis using a cohort-based Markov model to estimate the impact and costs of banning seven insecticides that were previously associated with PD in these counties as well as mixture exposures to some of these pesticides. We relied for our estimations on the cohort of 65- and 66-year-olds living in these counties who were unaffected by PD at baseline in 2020 and projected their incidence, costs, and reduction in quality-adjusted-life-years (QALY) loss due to developing PD over a 20-year period. We included a shiny app for modeling different scenarios (https://sherlockli.shinyapps.io/pesticide_pd_economics_part_2/).

Results: According to our scenarios, banning insecticides to reduce the occurrence of PD in three Central CA counties was cost-effective relative to not banning insecticides. In the worst-case scenario of exposure to a single pesticide, methomyl, versus none would result in an estimated 205 (95 % CI: 75, 348) additional PD cases or 12 % (95 % CI: 4 %, 20 %) increase in PD cases over a 20-year period based on residential proximity to pesticide applications. The increase in PD cases due to methomyl would increase health-related costs by $72.0 million (95 % CI: $5.5 million, $187.4 million). Each additional PD patient due to methomyl exposure would incur $109,327 (95 % CI, $5554, $347,757) in costs per QALY loss due to PD. Exposure to methomyl based on workplace proximity to pesticide applications generated similar estimates. The highest PD burden and associated costs would be incurred from exposure to multiple pesticides simultaneously.

Conclusion: Our study provides an assessment of the cost-effectiveness of banning specific insecticides to reduce PD burden in terms of health-related QALYs and related costs. This information may help policymakers and stakeholders to make decisions concerning the regulation of pesticides.

Keywords: Cost-effectiveness analysis; Markov model; Parkinson's disease; Pesticide.

MeSH terms

  • California
  • Cost-Benefit Analysis
  • Cost-Effectiveness Analysis
  • Humans
  • Insecticides*
  • Methomyl
  • Parkinson Disease* / epidemiology
  • Parkinson Disease* / prevention & control
  • Pesticides*

Substances

  • Insecticides
  • Methomyl
  • Pesticides